Stay updated on Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check5 days agoChange DetectedAdded a site-wide funding-status notice and Revision: v3.4.1; removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check12 days agoChange DetectedThe new version adds a glossary toggle, introduces color-coded highlights for additions and deletions, and updates the revision information.SummaryDifference0.5%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedOn 2026-01-09, the record history shows updates to Contacts/Locations and Study Status. The update is associated with Revision: v3.3.4, with a prior Revision: v3.3.3 removed on 2025-09-30.SummaryDifference0.3%

- Check48 days agoChange DetectedA new 'Revision: v3.3.3' tag appears; the 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' label were removed.SummaryDifference0.1%

- Check76 days agoChange DetectedRecord History shows an added Revision: v3.3.2 and removed Revision: v3.2.0, with no substantive changes to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedThe government funding lapse notice on the page has been removed. All other trial-related content and layout appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.